Skip to main content
. 2021 Jan 22;15(2):168–195. doi: 10.5009/gnl20288

Fig. 8.

Fig. 8

Meta-analysis of nine studies comparing bismuth quadruple therapy with other regimens after failure of first-line standard triple therapy. The pooled eradication rate of bismuth quadruple therapy as a second-line therapy was 75.5% (95% confidence interval [CI], 71.6% to 79.1%).